# Safety Study of Lifitegrast to Treat Dry Eye

> **NCT01636206** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 332 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** Lifitegrast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01636206
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-16
- **Primary completion:** 2014-03-03
- **Final completion:** 2014-03-03
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01636206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01636206, "Safety Study of Lifitegrast to Treat Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01636206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*